用AV优化传导系统节奏来治疗AV鼓膜病变:一个随机的交叉研究
Anja Zupan Mežnar1,2, Miha Mrak1, Wilfried Mullens3,4
1Department of Cardiology, University Medical Center Ljubljana, Ljubljana, Slovenia.
在患有严重一级AV阻塞的患者中,AV优化传导系统节奏 (CSP) 改善了运动能力和左心室中风体积. 这种节奏策略提供了症状缓解,大多数患者更喜欢.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗器械 医疗器械
背景情况:
- 严重的第一级心房关节 (AV) 阻塞可以模仿由于AV失调 (AV鼓膜变异) 的心力衰竭症状.
- 目前的指导方针建议对这种情况进行永久性起器植入,但支持证据有限.
研究的目的:
- 为了评估AV优化传导系统节奏 (CSP) 在症状严重的第一级AV阻塞和AV异步患者的有效性.
主要方法:
- 一项单盲交叉研究随机选择了14名症状严重的第一级AV阻塞患者接受AV优化的CSP或备份VVI节奏.
- 患者接受了每种节奏策略的3个月期,并比较了运动能力,心声学参数和症状发生.
主要成果:
- 与备用节奏相比,AV优化的CSP显著增加了运动工作量 (p=0.032) 和左心室中风体积 (LVSV,p<0.001).
- 观察到高峰VO2的趋势 (p=0.224).
- 患者报告症状有所改善,71%的人更喜欢AV优化的CSP (p=0.008).
结论:
- 对AV优化的CSP显示出增强运动能力,改善左心室中风体积和缓解第一级严重AV阻塞患者的症状的潜力.
更多相关视频
08:05Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
相关概念视频
Conduction System of the Heart
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Heart Failure Drugs: Inotropic Agents
Mechanism of Cardiac Arrhythmias
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
